UPK3A
From Wikipedia, the free encyclopedia
Uroplakin 3A
|
|||||||||||
Identifiers | |||||||||||
Symbol(s) | UPK3A; MGC119178; UPIII; UPK3 | ||||||||||
External IDs | MGI: 98914 HomoloGene: 5066 | ||||||||||
|
|||||||||||
RNA expression pattern | |||||||||||
Orthologs | |||||||||||
Human | Mouse | ||||||||||
Entrez | 7380 | 22270 | |||||||||
Ensembl | ENSG00000100373 | ENSMUSG00000022435 | |||||||||
Uniprot | O75631 | Q27QV3 | |||||||||
Refseq | NM_006953 (mRNA) NP_008884 (protein) |
NM_023478 (mRNA) NP_075967 (protein) |
|||||||||
Location | Chr 22: 44.06 - 44.07 Mb | Chr 15: 84.84 - 84.85 Mb | |||||||||
Pubmed search | [1] | [2] |
Uroplakin 3A, also known as UPK3A, is a human gene.[1]
[edit] References
[edit] Further reading
- Wu XR, Sun TT (1994). "Molecular cloning of a 47 kDa tissue-specific and differentiation-dependent urothelial cell surface glycoprotein.". J. Cell. Sci. 106 ( Pt 1): 31–43. PMID 8270634.
- Bonaldo MF, Lennon G, Soares MB (1997). "Normalization and subtraction: two approaches to facilitate gene discovery.". Genome Res. 6 (9): 791–806. PMID 8889548.
- Yuasa T, Yoshiki T, Tanaka T, et al. (1998). "Expression of uroplakin Ib and uroplakin III genes in tissues and peripheral blood of patients with transitional cell carcinoma.". Jpn. J. Cancer Res. 89 (9): 879–82. PMID 9818021.
- Lobban ED, Smith BA, Hall GD, et al. (1998). "Uroplakin gene expression by normal and neoplastic human urothelium.". Am. J. Pathol. 153 (6): 1957–67. PMID 9846985.
- Ogawa K, Johansson SL, Cohen SM (1999). "Immunohistochemical analysis of uroplakins, urothelial specific proteins, in ovarian Brenner tumors, normal tissues, and benign and neoplastic lesions of the female genital tract.". Am. J. Pathol. 155 (4): 1047–50. PMID 10514386.
- Olsburgh J, Harnden P, Weeks R, et al. (2003). "Uroplakin gene expression in normal human tissues and locally advanced bladder cancer.". J. Pathol. 199 (1): 41–9. doi: . PMID 12474225.
- Tu L, Sun TT, Kreibich G (2003). "Specific heterodimer formation is a prerequisite for uroplakins to exit from the endoplasmic reticulum.". Mol. Biol. Cell 13 (12): 4221–30. doi: . PMID 12475947.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi: . PMID 12477932.
- Koga F, Kawakami S, Fujii Y, et al. (2004). "Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder.". Clin. Cancer Res. 9 (15): 5501–7. PMID 14654529.
- Collins JE, Wright CL, Edwards CA, et al. (2005). "A genome annotation-driven approach to cloning the human ORFeome.". Genome Biol. 5 (10): R84. doi: . PMID 15461802.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121–7. doi: . PMID 15489334.
- Schönfelder EM, Knüppel T, Tasic V, et al. (2006). "Mutations in Uroplakin IIIA are a rare cause of renal hypodysplasia in humans.". Am. J. Kidney Dis. 47 (6): 1004–12. doi: . PMID 16731295.
- Zeng Y, Wu XX, Homma Y, et al. (2007). "Uroplakin III-delta4 messenger RNA as a promising marker to identify nonulcerative interstitial cystitis.". J. Urol. 178 (4 Pt 1): 1322–7; discussion 1327. doi: . PMID 17698128.